Briefing Pharma ReFi Telix Pharmaceuticals raises USD550m in convertible note refinance 14 April 2026
Briefing Joint Development Telix to receive $57m through new partnership with Regeneron 13 April 2026
Briefing Green Light FDA approves new drug application for Telix’s brain cancer imaging agent 10 April 2026
Briefing Cancer Clarity Telix Pharmaceuticals resubmits brain cancer imaging application to the FDA 16 March 2026
Briefing Trial success Telix Pharmaceuticals rallies after positive results on prostate trial 10 March 2026
Briefing Cancer Free Telix Pharmaceuticals submits application for brain cancer imaging in Europe 18 February 2026
Briefing Earnings Szn Telix Pharmaceuticals hits upgraded FY25 guidance on strong Q4 revenue 20 January 2026
Briefing China Clearance Telix Pharmaceuticals secures China approval for prostate cancer imaging filing 20 January 2026
Briefing Strong Sales Telix upgrades 2025 revenue guidance after 53% lift in September quarter 14 October 2025
Briefing Payment Plan Telix shares soar on new US payment status for imaging agent Gozellix 23 September 2025
Briefing Top Rated Telix Pharmaceuticals shares surge as Citi starts coverage with ‘buy’ rating 19 September 2025
Briefing Pharma Fall Telix shares tank 20% as FDA flags concerns over novel imaging agent 28 August 2025
Briefing Increased Investment Telix shares soar after reiterating 2025 revenue guidance 21 August 2025
Briefing Pharma Fall CSL, Telix lead biotech selloff after Eli Lilly tanks on Wall Street 8 August 2025
Briefing US Expansion Telix Pharmaceuticals shares plunge on operational expenditure update 5 August 2025
Briefing Clinical Performance Telix Pharmaceuticals revenue jumps 63%, announces regulatory inquiry 22 July 2025
Briefing Price drop ASX-listed pharmaceutical companies sink after Trump post on drug costs 12 May 2025
Briefing Health Hit Telix shares sink after FDA blocks approval for glioma imaging agent 28 April 2025
Briefing Done Deal Telix Pharmaceuticals ties up purchase of new theranostic candidates 12 March 2025
Briefing Profit prescription Telix Pharmaceuticals shares soar on full-year profit growth 21 February 2025
Briefing Green Light Telix shares rise as EU approves prostate cancer treatment Illuccix 17 January 2025
Briefing Payment Plan Telix shares climb on payment changes for US diagnostic radiotherapy treatments 4 November 2024
Briefing Cancer Care Telix shares advance on US FDA application approval for glioma imaging agent 24 October 2024
Briefing Not Buying It Telix shares fall as Morningstar calls market 'too optimistic' on Illuccix sales 21 October 2024
